Autoimmune Diseases  >>  methotrexate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methotrexate / Generic mfg.
NCT02884635: A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

Completed
2a
72
Japan
ASP1707, Placebo, Methotrexate
Astellas Pharma Inc
Rheumatoid Arthritis
10/17
10/17
NCT02693210: A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis

Completed
2
161
Canada, Europe, RoW
Cyclophosphamide, Methotrexate, Placebo Cyclophosphamide, Placebo Methotrexate, Placebo Rituximab, Rituximab
Hoffmann-La Roche
Rheumatoid Arthritis
08/02
08/04
NCT00760864 / 2004-002157-30: Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

Completed
2
432
US
TAK-715 and methotrexate, Methotrexate
Takeda
Arthritis, Rheumatoid
09/05
09/05
NCT00620685: A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate

Completed
2
27
US
Placebo, PH-797804
Pfizer
Arthritis, Rheumatoid
10/08
10/08
NCT00760968 / 2006-003054-26: Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

Completed
2
224
Europe, RoW
TAK-783 and methotrexate, Rheumatrex®., Methotrexate
Takeda
Arthritis, Rheumatoid
02/09
02/09
NCT01225393 / 2010-021577-37: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

Checkmark EULAR 2013
May 2013 - May 2013: EULAR 2013
Completed
2
211
US, Europe, RoW
MLTA3698A, adalimumab, leflunomide, methotrexate, placebo
Genentech, Inc.
Rheumatoid Arthritis
07/12
 
NCT01618968: Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

Completed
2
49
US
MTX, Commercially available 2.5 mg MTX oral tablets, VIBEX MTX
Antares Pharma Inc.
Rheumatoid Arthritis (RA)
08/12
08/12
NCT01164579 / 2010-020890-18: Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

Checkmark ACR-ARHP 2014: Rheumatoid Arthritis
Oct 2014 - Oct 2014: ACR-ARHP 2014: Rheumatoid Arthritis
Completed
2
109
US, Europe, RoW
Tasocitinib plus Methotrexate, Tofacitinib plus placebo methotrexate, Placebo tofacitinib plus Methotrexate
Pfizer
Rheumatoid Arthritis
11/13
11/13
NCT02029599: The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

Completed
2
240
RoW
Fang yi qing feng shi granule, placebo, Methotrexate, Acetaminophen tablets
Maoxiang Group Jilin Pharmaceutical Co., Ltd.
Rheumatoid Arthritis
08/15
 
NEXUS, NCT02379091 / 2013-002805-76: Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Completed
2
108
Japan, Europe, RoW
Namilumab, Placebo, Methotrexate, Folic/folinic acid
Takeda
Rheumatoid Arthritis
05/16
12/16
TELLUS, NCT02393378 / 2014-002945-23: Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

Terminated
2
7
Europe, RoW
Namilumab, Adalimumab, Methotrexate, Folic Acid
Takeda
Rheumatoid Arthritis
06/16
11/16

Download Options